journal article·2025-12Open access

A proposed crystal structure of fruquintinib Form I, C 21 H 19 N 3 O 5

James A. Kaduk, Anja Dosen, Tom Blanton

Powder Diffraction· Volume 40· Issue 4

Abstract

Abstract The crystal structure of fruquintinib Form I has been solved and refined using synchrotron X-ray powder diffraction data and optimized using density functional theory techniques. Fruquintinib Form I crystallizes in space group C2 (#5) with a = 35.4167(22), b = 3.90500(12), c = 26.9370(11) Å, β = 108.0290(22)°, V = 3,542.52(26) Å 3 , and Z = 8 at 298 K. The crystal structure consists of double layers of each of the two independent molecules parallel to the ab -plane. These layers stack along the short b -axis. N–H···N hydrogen bonds link the layers. Most of the C–H···N and C–H···O hydrogen bonds are intramolecular. The powder pattern has been submitted to ICDD for inclusion in the Powder Diffraction File ™ (PDF ® ).
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Synthesis and biological activity · Multicomponent Synthesis of Heterocycles · Microwave-Assisted Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Illinois Institute of Technology

North Central College

International Centre for Diffraction Data (ICDD)

Funding

International Centre for Diffraction Data

References (34)

Show source-provided references
1. 10.1007/BF0054909610.1007/BF00549096 ↗
2. 2024
3. 10.1107/S160057752100249610.1107/S1600577521002496 ↗
4. 2013
5. 10.1107/S160057672100291010.1107/S1600576721002910 ↗
6. 10.1107/S002188980201523610.1107/S0021889802015236 ↗
7. 10.1017/S088571561400051710.1017/S0885715614000517 ↗
8. Open Babel: An Open Chemical Toolbox
9. 10.1107/S205252061402290210.1107/S2052520614022902 ↗
10. 10.1021/acs.jctc.2c0095810.1021/acs.jctc.2c00958 ↗
11. 2023
12. 10.1107/S002188981101462210.1107/S0021889811014622 ↗
13. 10.1017/S088571561400090610.1017/S0885715614000906 ↗
14. 2023
15. Yu, Yinglu , Chen, Jinyao , and Yi, Dongxu . 2016b. “Quinazoline Derivative C Crystal Form and Preparation Method and Application Thereof.” Chinese Patent CN105777722A.
16. Yu, Yinglu , Chen, Jinyao , and Yi, Dongxu . 2016c. “Quinazoline Derivative B Crystal Form, Preparation Method and Application Thereof.” Chinese Patent CN105777723A.
17. Yu, Yinglu , Chen, Jinyao , and Yi, Dongxu . 2016a. “Quinazoline Derivative A Crystal Form and Preparation Method and Application Thereof.” Chinese Patent CN105777721A.
18. Wu, Zhenping , Li, Wenji , and Chu, Yuping . 2016. “6-(6,7-Dimethoxyquinazolin-4-yloxy)-N,2-Dimethylbenzofuran-3-Carboxamide Crystal Form.” Chinese Patent CN105461702A.
19. 10.1017/S088571562400015010.1017/S0885715624000150 ↗
20. 10.1107/S002188989800600110.1107/S0021889898006001 ↗
21. 10.1002/jcph.7000110.1002/jcph.70001 ↗
22. A New Law of Crystal Morphology Extending the Law of Bravais
23. 10.1021/ci049780b10.1021/ci049780b ↗
24. 10.1063/1.46788210.1063/1.467882 ↗
25. Sheng, X. , and Sheng, X. . 2019. “Fruquintinib Eutectic Crystal, Preparation Method Therefor, Composition, and Uses Thereof.” International Patent Application WO 2019/183916 A1.
26. 10.1107/S002188981300353110.1107/S0021889813003531 ↗
27. Bravais · 1866
28. 10.1093/nar/gkac95610.1093/nar/gkac956 ↗
29. 10.1107/S160057671901409210.1107/S1600576719014092 ↗
30. 10.1002/wcms.136010.1002/wcms.1360 ↗
31. 10.1016/0927-0256(96)00008-010.1016/0927-0256(96)00008-0 ↗
32. 10.3406/bulmi.1907.282010.3406/bulmi.1907.2820 ↗
33. 2024
34. Sheng, X. , and Sheng, X. . 2018. “Fruquintinib Eutectic Crystal, Preparation Method Therefor, Composition, and Uses Thereof.” U.S. Patent Application 2021/0155613.